Abstract
Impact of homologous recombination repair (HRR) or nucleotide excision repair (NER) deficiency on sensitivity to antibody drug conjugate (ADC) payloads in urothelial cancer.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have